Rating History for Verona Pharma (VRNA) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for VRNA
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/10/2025 Yasmeen Rahimi Downgrade Neutral
(Overweight)		 107.00
(N/A)		 104.77
(106.91)		 2.04% Details